Status:
UNKNOWN
Treatment of Hypertension in Tibetan Adult Population
Lead Sponsor:
West China Hospital
Conditions:
Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Several surveys had revealed that Tibetan adults had high prevalence of hypertension. However, there was no research studying the antihypertensive effect of the known drugs in Tibetan. The main arms o...
Detailed Description
Several surveys had revealed that Tibetan adults had high blood pressure(BP)and prevalence of hypertension than other parts of China and were also higher than those in developed nations as well. For e...
Eligibility Criteria
Inclusion
- Adult Tibetan, who have been living in the Tibetan Plateau since he/she was born.
- Consistent with diagnosed hypertension, blood pressure, for 1-3 grade.
- Aged 18-80 years old.
- To sign informed consent.
Exclusion
- diagnosis of secondary hypertension
- Hypertensive emergencies and urgencies
- Malignant hypertension
- Bilateral renal artery stenosis, Chronic Kidney Disease（CKD）, serum creatinine\> 133μmol / L.
- Suffering from congenital heart disease, rheumatic heart disease, hypertrophic cardiomyopathy, aortic stenosis.
- Occurred within the past 6 months who had a stroke or transient ischemic attack (TIA), unstable angina, myocardial infarction, percutaneous transluminal coronary angioplasty (PTCA).
- clinical significance of arrhythmia
- Active liver disease, history of chronic persistent hepatitis, alanine aminotransferase（ALT）\> upper limit of normal.
- Pregnancy, pregnancy or breast-feeding women to prepare.
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2016
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT02217852
Start Date
August 1 2014
End Date
July 1 2016
Last Update
August 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital
Chengdu, Sichuan, China, 610041